| 000 | 01517 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515125048.0 | ||
| 264 | 0 | _c20081224 | |
| 008 | 200812s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gut.2008.152496 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBinion, D G | |
| 245 | 0 | 0 |
_aCurcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. _h[electronic resource] |
| 260 |
_bGut _cNov 2008 |
||
| 300 |
_a1509-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIrritable Bowel Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xbiosynthesis |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xmetabolism |
| 700 | 1 | _aOtterson, M F | |
| 700 | 1 | _aRafiee, P | |
| 773 | 0 |
_tGut _gvol. 57 _gno. 11 _gp. 1509-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2008.152496 _zAvailable from publisher's website |
| 999 |
_c18078982 _d18078982 |
||